BOPA 2016 Videos and BOPA Publications Now Available!
The BOPA Committee are delighted to announce that the key highlights from the BOPA Symposia at Manchester are now available in the Education and Training section of the new website…
Find out the latest with BOPA, Oncology, and upcoming events
The BOPA Committee are delighted to announce that the key highlights from the BOPA Symposia at Manchester are now available in the Education and Training section of the new website…
The regimen-specific consent forms for gynaecological cancers have been published on the Cancer Research UK (CRUK) website. There are 24 forms for this tumour group: BEP (5 day) Bevacizumab…
The regimen-specific consent forms for melanoma and a generic form for immunotherapy have been published on the Cancer Research UK (CRUK) website. There are 13 forms for melanoma: Carboplatin…
The committee is pleased to share our latest newsletter, in which we update you on our recent annual planning meeting and committee activities. http://www.eventsinteractive.com/succinct/images/BOPA_NEWSLETT_DEC_2016_v1.3.pdf Remember BOPA is all about its members;…
BOPA and PRUK are delighted to grant the 2016 BOPA-PRUK Research Award to John Minshull at University College London Hospital. BOPA and PRUK (Pharmacy Research UK) are working together to…
Remember we asked delegates to update their profile picture on the new BOPA website during the symposium weekend in October and that we would draw a prize winner from these enthusiastic folk? Well, congratulations…
The BOPA committee are pleased to announce that the new chair of BOPA is Steve Williamson. Steve is a Consultant Cancer Pharmacist based at Northumbria Healthcare Trust in the North…
DATE FOR DIARY 6th – 8th October 2017 Scottish Exhibition and Conference Centre
The British Oncology Pharmacy Association (BOPA) is pleased to announce the re-launch of its website, bopawebsite.org. The completely redesigned website provides a modern user-friendly navigation compatible with mobile devices, bringing…
The Chemotherapy and Pharmacy Advisory Service (CPAS) are currently seeking new panel members. The CPAS panel review draft and near final protocols to support investigators and each panel member will be asked…
The Chemotherapy Board, with support from Cancer Research UK, has published guidance on consent for Systemic Anti-Cancer Therapy (SACT). The guidance is accompanied by national SACT site – and regimen-specific…
In response to concerns that patients often delay reporting serious Systemic Anti-Cancer Therapy (SACT) side effects, the National Chemotherapy Board (NCB) has developed guidance to improve side effect reporting. Two…